This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pasteur S.a.. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Raphaëlle El Habib: Innovator in HIV Research
Introduction
Raphaëlle El Habib is a notable inventor based in Chaponost, France. He has made significant contributions to the field of immunology, particularly in the development of novel polypeptide antigens for therapeutic and prophylactic immunization against HIV-related infections.
Latest Patents
El Habib holds a patent for the GP41 antigen. This invention comprises novel polypeptide antigens that mimic the intermediate state of gp41. The polypeptide is capable of inducing antibodies that neutralize primary isolates of HIV. Additionally, the invention includes compositions comprising the polypeptide and methods of using it.
Career Highlights
Raphaëlle El Habib is associated with Aventis Pasteur S.A., a leading company in the field of vaccines and immunization. His work focuses on innovative solutions to combat HIV, showcasing his commitment to advancing medical science.
Collaborations
El Habib has collaborated with notable colleagues such as Michel Chevalier and Tino Krell, contributing to a dynamic research environment that fosters innovation.
Conclusion
Raphaëlle El Habib's work in developing polypeptide antigens represents a significant advancement in the fight against HIV. His contributions to immunology and collaboration with esteemed colleagues highlight his dedication to improving public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile